massarray methylation platform Search Results


massarray methylation platform  (agena bioscience)
96
agena bioscience massarray methylation platform
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Massarray Methylation Platform, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/Methylation/pmc06284780-181-20-23
Average 96 stars, based on 1 article reviews
massarray methylation platform - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
massarray epityper platform  (Sequenom)
86
Sequenom massarray epityper platform
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Massarray Epityper Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/massarray+platform/pm41486283-69-20-23
Average 86 stars, based on 1 article reviews
massarray epityper platform - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
sequenom massarray platform  (CapitalBio Corporation)
90
CapitalBio Corporation sequenom massarray platform
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Sequenom Massarray Platform, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/sequenom+massarray+platform/pm36907530-113-6-8
Average 90 stars, based on 1 article reviews
sequenom massarray platform - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
massarray platform  (CapitalBio Corporation)
90
CapitalBio Corporation massarray platform
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Massarray Platform, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/massarray+platform/pmc03508711-284-11-13
Average 90 stars, based on 1 article reviews
massarray platform - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
massarray-system-1  (agena bioscience)
96
agena bioscience massarray-system-1
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Massarray System 1, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/massarray-system-1/custom%40massarray-system-1%4037016382
Average 96 stars, based on 1 article reviews
massarray-system-1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
massarray system  (agena bioscience)
97
agena bioscience massarray system
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Massarray System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/MassARRAY+System/custom%4010026%4037016382
Average 97 stars, based on 1 article reviews
massarray system - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
methylation reagents  (agena bioscience)
90
agena bioscience methylation reagents
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Methylation Reagents, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/Methylation+Reagents/custom%4010249d%4024433282
Average 90 stars, based on 1 article reviews
methylation reagents - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
the sequenom massarray platform  (BGI Shenzhen)
90
BGI Shenzhen the sequenom massarray platform
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
The Sequenom Massarray Platform, supplied by BGI Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/sequenom+massarray+platform/bio_rxiv__030965-228-2-4
Average 90 stars, based on 1 article reviews
the sequenom massarray platform - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
all-mentions  (agena bioscience)
99
agena bioscience all-mentions
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
All Mentions, supplied by agena bioscience, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/all-mentions/custom%40all-mentions%4032343702
Average 99 stars, based on 1 article reviews
all-mentions - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
pharmacogenetics  (agena bioscience)
96
agena bioscience pharmacogenetics
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Pharmacogenetics, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/Pharmacogenetics/custom%40pharmacogenetics-1%4029669044
Average 96 stars, based on 1 article reviews
pharmacogenetics - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
sample integrity  (agena bioscience)
96
agena bioscience sample integrity
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Sample Integrity, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/Sample+Integrity/custom%40sample-integrity-1%4029669044
Average 96 stars, based on 1 article reviews
sample integrity - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
hereditary genetics  (agena bioscience)
96
agena bioscience hereditary genetics
<t>Methylation</t> analyses of 12 imprinted iDMRs by <t>MassARRAY</t> in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="250" height="auto" />
Hereditary Genetics, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+methylation+platform/Hereditary+Genetics/custom%40hereditary-genetics-1%4029669044
Average 96 stars, based on 1 article reviews
hereditary genetics - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Methylation analyses of 12 imprinted iDMRs by MassARRAY in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ <xref rid=41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391. " width="100%" height="100%">

Journal: Epigenetics

Article Title: Characterization of multi-locus imprinting disturbances and underlying genetic defects in patients with chromosome 11p15.5 related imprinting disorders

doi: 10.1080/15592294.2018.1514230

Figure Lengend Snippet: Methylation analyses of 12 imprinted iDMRs by MassARRAY in patients with BWS and SRS with known epimutations at ICR1 or ICR2. Cases with MLID are underlined. Aberrant methylation was defined as methylation values deviating +/- two standard deviations from the mean value observed in amniotic fluid (AF) or blood control samples. Different shades of yellow indicate 5% intervals of LOM (with light yellow corresponding to slight LOM and dark yellow corresponding to heavy LOM), while different shades of blue represent 5% intervals of GOM (from light blue corresponding to slight GOM to dark blue indicating heavy GOM). The last two columns contain ICR1/ICR2 methylation values determined by pyrosequencing, according to protocols previously described [ 41 ]. *t-test ICR1 MassARRAY vs. ICR1 pyrosequencing: P = 0.2302. § t-test ICR2 MassARRAY vs. ICR2 pyrosequencing: P = 0.4391.

Article Snippet: Methylation profile of 12 iDMRs frequently involved in MLID in BWS/SRS [ , , , ] was investigated by the MassARRAY methylation platform (Agena Bioscience, Hamburg, Germany).

Techniques: Methylation, Control